CERFLUX Announces Breast Cancer Research Foundation of Alabama Award
Share Article BIRMINGHAM, Ala. (PRWEB) December 18, 2020 CerFlux, creators of an advanced personalized medicine solutions to identify the most efficient and effective cancer treatments for each patient on an individualized basis, announced today the receipt of a $50,000 Breast Cancer Research Foundation of Alabama (BCRFA) grant to help fund new imaging technology at the CerFlux lab in downtown Birmingham.
This imaging technology will provide the added efficiency critical for processing breast cancer tumor specimens in the CerFlux Personalized Oncology Efficacy Test (POET). The personalized medicine approach at the heart of POET addresses the critical, urgent, and unmet need for accessible and affordable predictive tools that identify optimal systemic therapy regimens and eliminate ineffective options. By providing an individualized treatment pla